Phase I
Studies in healthy volunteers are developped in 2 centres having a panel of young subjects and beds fully monitored where clinical and pharmacodynamic data are processed and computerized. Studies include : Ascending dose Tolerance Bioavailability Pharmacokinetic
Radiolabelled drug metabolism are developped through a Belgian centre.
Phase II to phase IV
BIOTEC CENTRE works in close contact with high level academic teams.
Clinical trials are conducted in France and EEC countries.
Studies in "exposed" populations
For a compound with a high urinary elimination, studies are developped in patients having renal insufficiency (3 centres).
For a compound having a high first pass effect, studies are developped in patients having hepatic insufficiency (1 centre).